TRENTON - Drugmaker Wyeth is seeking U.S. approval to sell a new version of its blockbuster infant vaccine Prevnar that protects against more strains of a germ that causes pneumonia.
TRENTON - Drugmaker Wyeth is seeking U.S. approval to sell a new version of its blockbuster infant vaccine Prevnar that protects against more strains of a germ that causes pneumonia.
